PARSIPPANY, N.J., Oct. 23 /PRNewswire/ -- Valeritas, LLC, a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced today that John Timberlake, Executive Vice President and General Manager of Valeritas, LLC was awarded the distinguished Executive of Year award by the Diabetes Foundation, an organization dedicated to the needs of patients with diabetes in New Jersey.
"John's continued commitment to improving the quality of care for patients with diabetes made him an obvious choice for Executive of the Year," said Sam Fusco, Chairman of the Board of the Diabetes Foundation. "We are honored to have John among this elite group of executives, and look forward to working with him to improve the lives of people suffering with diabetes in New Jersey."
Mr. Timberlake has devoted nearly half of his 21-year career to the commercialization of new treatments for patients with diabetes. In his current role at Valeritas, he is focused on commercializing and launching the lead product in the Valeritas portfolio -- the h-Patch(TM) disposable insulin delivery device, a once-daily, simple-to-use, discreet insulin delivery device that provides both a continuous set basal rate of insulin and on-demand bolus dosing for mealtime coverage. The h-Patch(TM) is expected to be available in the New Jersey area in the first half of 2008 and nationally by the end of 2008.
"I am very honored to accept this award from an organization dedicated
to the fight against diabetes," said Mr. Timberlake. "While there have been
great strides in improving treatment options for people with diabetes and
there is less stigma about taking insulin, more needs to be done. At
Valeritas, the h-Patch(TM) technology has been designed to provide patients
with a drug delivery option that mimics the physiologic distribution of
insulin in a simple fashion which will improve compliance and ultimately
lead to better control. I am
|SOURCE Valeritas, LLC|
Copyright©2007 PR Newswire.
All rights reserved